Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmacyclics Inc
PCYC
Healthcare
Biotechnology
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PCYC)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
chubster56
X
View Profile
View Bullboard History
Comment by
chubster56
on Oct 24, 2013 6:39pm
RE:RE: There are no triple tops
Long live the CUZ. He never gave a bad buy call
(4)
•••
skyhi0
X
View Profile
View Bullboard History
Post by
skyhi0
on Oct 11, 2013 12:08pm
Upgrade today
Goldman Sachs upgraded Pharmacyclics (NASDAQ: PCYC) from Neutral to Buy with a price target of $170.00 (from $111.00). Analyst Navdeep Singh noted ibrutinib launch as checks indicate strong uptake and
...more
(0)
•••
BCsilver
X
View Profile
View Bullboard History
Post by
BCsilver
on Sep 27, 2013 6:28pm
100 nope 33% higher
and kamer just told his followers all about it
(0)
•••
cousinwoolie
X
View Profile
View Bullboard History
Comment by
cousinwoolie
on Feb 23, 2013 1:13pm
RE: There are no triple tops
PCYC still headed for 100
(0)
•••
cousinwoolie
X
View Profile
View Bullboard History
Post by
cousinwoolie
on Jan 26, 2013 6:59pm
There are no triple tops
PCYC is headed for a hundred
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
High-grade gold potential in the world’s best mining jurisdiction
Uranium Explorer to Commence Drill Program at Clearwater West Project in Saskatchewan